文献速递膀胱癌与上尿路尿路上皮癌

初治膀胱尿路上皮癌患者尿液与组织微生物组的性别特异性改变

Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.
PubMed 文献 · Eur Urol Oncol · 2020-04-25

本研究对166份来自初治膀胱癌根治术患者及健康对照的尿液和配对膀胱组织样本进行16S rDNA微生物组分析,旨在明确尿液与膀胱组织的性别特异性微生物差异,以及尿液微生物组对组织微环境的代表性。结果发现女性膀胱癌患者尿液中Klebsiella属较健康对照更常见,而男性中未发现临床相关差异菌;肿瘤组织中Burkholderia属在男女两性中均较非肿瘤组织更丰富;尿液微生物组与配对膀胱组织共享超过80%的细菌科,提示尿液微生物组可作为组织细菌环境的合理替代。

要点

  • 女性膀胱癌患者尿液中Klebsiella属较健康对照更常见。
  • 肿瘤组织中Burkholderia属在男女两性中均较非肿瘤组织更丰富。
  • 尿液与配对膀胱组织共享超过80%的细菌科,尿液微生物组可合理代表组织细菌环境。

核心结论

  • 初治膀胱癌患者尿液和组织微生物组存在性别特异性差异,女性尿液中Klebsiella属更常见,肿瘤组织中Burkholderia属在男女两性中均更丰富。
  • 尿液微生物组与配对膀胱组织共享超过80%的细菌科,可作为组织细菌环境的合理替代。

研究设计与样本

  • 对166份来自初治膀胱癌根治术患者及健康对照的尿液和配对膀胱组织样本进行16S rDNA微生物组分析。

主要发现

  • 女性膀胱癌患者尿液中Klebsiella属较健康对照更常见,男性中未发现临床相关细菌差异富集。
  • 肿瘤组织中Burkholderia属在男女两性中均较非肿瘤组织更丰富。
  • 尿液微生物组与配对膀胱组织共享超过80%的细菌科。

临床怎么用

  • 尿液微生物组可作为膀胱组织细菌环境的替代指标,便于无创监测。
  • Klebsiella属和Burkholderia属可能参与膀胱癌生物学行为,值得进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Comprehensive characterization of the urinary and urothelium-bound microbiomes in bladder cancer (BCa) and healthy state is essential to understand how these local microbiomes may play a role in BCa tumorigenesis and response to therapy, as well as to explain sex-based differences in BCa pathobiology. Performing 16 s rDNA microbiome analysis on 166 samples (urine and paired bladder tissues) from therapy-naïve BCa patients undergoing radical cystectomy and healthy controls, we defined (1) sex-specific microbiome differences in the urine and bladder tissue, and (2) representativeness of the tissue microenvironment by the voided urinary microbiome. The genus Klebsiella was more common in the urine of female BCa patients versus healthy controls, while no clinically relevant bacteria were found differently enriched in men. In tissues, the genus Burkholderia was more abundant in the neoplastic versus the non-neoplastic tissue in both sexes, suggesting a potential role in BCa pathobiology. Lastly, we found that the urinary microbiome shares >80% of the bacterial families present in the paired bladder tissue, making the urinary microbiome a fair proxy of the tissue bacterial environment. PATIENT SUMMARY: We identified specific bacteria present in the urine and tissues of male and female bladder cancer patients. These novel data represent a first step toward understanding the influence of the bladder microbiome on the development of bladder cancer and on the response to intravesical and systemic therapies.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Pederzoli F, Ferrarese R, Amato V, et al. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients. Eur Urol Oncol. 2020. PMID: 32345542. doi:10.1016/j.euo.2020.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。